Your browser doesn't support javascript.
loading
The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response.
De Azevedo, Justine; Mourtada, Jana; Bour, Cyril; Devignot, Véronique; Schultz, Philippe; Borel, Christian; Pencreach, Erwan; Mellitzer, Georg; Gaiddon, Christian; Jung, Alain C.
Afiliação
  • De Azevedo J; Laboratory Streinth, Université de Strasbourg-Inserm, UMR_S 1113 IRFAC, 67200 Strasbourg, France.
  • Mourtada J; Laboratory Streinth, Université de Strasbourg-Inserm, UMR_S 1113 IRFAC, 67200 Strasbourg, France.
  • Bour C; Laboratory Streinth, Université de Strasbourg-Inserm, UMR_S 1113 IRFAC, 67200 Strasbourg, France.
  • Devignot V; Laboratoire de Biologie Tumorale, Institut de Cancérologie Strasbourg Europe, 67200 Strasbourg, France.
  • Schultz P; Laboratory Streinth, Université de Strasbourg-Inserm, UMR_S 1113 IRFAC, 67200 Strasbourg, France.
  • Borel C; Laboratory Streinth, Université de Strasbourg-Inserm, UMR_S 1113 IRFAC, 67200 Strasbourg, France.
  • Pencreach E; Department of Otorhinolaryngology and Head and Neck Surgery, Hôpitaux Universitaires de Strasbourg, 67200 Strasbourg, France.
  • Mellitzer G; Laboratory Streinth, Université de Strasbourg-Inserm, UMR_S 1113 IRFAC, 67200 Strasbourg, France.
  • Gaiddon C; Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, 67200 Strasbourg, France.
  • Jung AC; Laboratory Streinth, Université de Strasbourg-Inserm, UMR_S 1113 IRFAC, 67200 Strasbourg, France.
Cells ; 11(18)2022 09 14.
Article em En | MEDLINE | ID: mdl-36139440

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cetuximab / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Cells Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cetuximab / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Cells Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França